DBCO-P-LPK is a DBCO-modified colorectal cancer-specific binding peptide that serves as a key intermediate for targeted anticancer conjugates. DBCO-P-LPK enables the synthesis of the P-LPK-Camptothecin (HY-16560) conjugate. DBCO-P-LPK is applicable to the research of colorectal cancer[1].
Molekulargewicht:
1578.78
Formel:
C73H107N15O22S
Target-Kategorie:
Drug Intermediate
Anwendungsbeschreibung:
MCE Product type: Peptides
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
